FADS1 and cancer: Alterations to the activity of the FADS2 and FADS1 gene products, delta-6 and delta-5 desaturase, respectively, has been associated with several diseases, such as diabetes, cardiovascular disease, inflammation, and cancer (breast, melanoma, lung) [27–30].